CompanyDeals

Shanghai Pharmaceuticals and Sanofi Broaden Collaboration to Include Nationwide Disease Management

CompanyLegal / IP

Servier Faces $475 Million Penalty Over Banned Antidiabetic Drug Mediator in France

CompanyLegal / IP

J&J Shareholders Cleared to Sue Over Hidden Asbestos Risks in Talc Products

Policy / Regulatory

China’s CDE Releases Guidelines for CGT Clinical Trials Communication

Policy / Regulatory

China’s NHC Unveils Plan to Conserve Drug Resources and Reduce Waste

Policy / Regulatory

China’s NHC Unveils Guidelines to Fortify County-Level Medical Communities

CompanyDeals

Roche to Expand Diagnostics Portfolio with Acquisition of LumiraDx Technology

CompanyDrug

Huadong Medicine Ends Collaboration on vTv’s TTP273 for Diabetes Treatment

CompanyDeals

Roche Secures Diagnostics Deal with LumiraDx for $295M

CompanyDeals

Huadong Medicine Cancels Collaboration with vTv Therapeutics on TTP273 for Type 2 Diabetes Drug

CompanyDrug

Jiangsu Recbio’s REC610 Shingles Vaccine Shows Positive Results in First-In-Human Study

CompanyDrug

Innovent Biologics Initiates Phase III Trial for Mazdutide in Obesity Treatment